A study to see the effect of Bilvadi Yog in Abnormal Uterine bleeding.

A Randomised Controlled Clinical Trial To Study The Effect Of Bilvadi Yoga In Asrigdara With Special Reference To Abnormal Uterine Bleeding - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/071940

Enrollment

Registered

2024-08-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients complaining symptoms of Asrigdara such as excessive and prolonged uterine bleeding with PBAC score is greater than or equal to 150. 2. Female patients with age group 18 to 50 years.

Exclusion criteria

Exclusion criteria: 1. Patients with Systemic Hemorrhagic Disorders. 2. Patients with Structural abnormalities like Uterine Polyps, Uterine Erosions, Uterine Fibroids, Ovarian mass, Malignancy of Uterus or Cervix, etc. 3. Postdelivery bleeding, Post MTP bleeding, Post D and C bleeding. 4. Patients with Intra Uterine Contraceptive Device. 5. Injuries to Reproductive tract. 6. Systemic disorders like, Diabetes Mellitus, Severe anemia.

Design outcomes

Primary

Measure	Time frame
Reduction in Sign and Symptoms of Asrugdara after Giving Bilvadi YogaTimepoint: At baseline and 7 days Reduction in Sign and Symptoms of Asrugdara after Giving Bilvadi Yoga	—

Secondary

Measure	Time frame
where the trial group stands in comparison with control groupTimepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Shruti Shivaji Zendage

SMBT Ayurved College and Hospital

drpradnya2013@gmail.com9766310638

Outcome results